[A means of accelerated determination of blood clotting factor XIII activity]. 1972

M A Umanskii, and V M Berlint

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M A Umanskii, and V M Berlint
January 1981, Wiadomosci lekarskie (Warsaw, Poland : 1960),
M A Umanskii, and V M Berlint
January 1974, Voprosy meditsinskoi khimii,
M A Umanskii, and V M Berlint
October 1971, Arzneimittel-Forschung,
M A Umanskii, and V M Berlint
August 1998, Biochemical and biophysical research communications,
M A Umanskii, and V M Berlint
August 1979, Biochemical Society transactions,
M A Umanskii, and V M Berlint
June 1974, The Journal of the American Osteopathic Association,
M A Umanskii, and V M Berlint
April 1975, Japanese journal of medical science & biology,
M A Umanskii, and V M Berlint
January 1988, Advances in experimental medicine and biology,
Copied contents to your clipboard!